Nocturia is fairly prevalent. A review by Bosch and Weiss [3] noted that most older men and women experience at least 1 void per night and on average two thirds of patients experience 2 or more voids ...
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, has launched desmopressin acetate for injection, which is a generic of Ferring Pharmaceutical’s DDAVP ...
Ferring Pharmaceuticals US is voluntarily recalling all lots on the market of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE® Nasal Spray 1.5 mg/mL listed ...
Japan: A large post-marketing surveillance study in Japan has provided important real-world insights into the long-term ...
The FDA has assigned a Prescription Drug User Fee Act target date of February 25, 2026 to the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ET-600 ...
DESMODA is the first and only FDA-approved desmopressin oral solution Commercial launch expected on March 9 th DESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results